Neurotech Collider Lab Collaborates with Brain Capital Alliance to Promote Global Brain Health
The Neurotech Collider Lab, housed at UC Berkeley’s Sutardja Center for Entrepreneurship & Technology (SCET) and Bakar Bioenginuity Hub (BBH) is collaborating with the Brain Capital Alliance (BCA), a global effort to promote brain health and well-being, to accelerate the development and commercialization of neurotechnology solutions.
The collaboration was highlighted at the recent 77th United Nations General Assembly, where Neurotech Collider Lab Director Gail Gannon joined Dr. Harris Eyre, a leading figure in the brain capital movement and Lead of the BCA, to discuss the importance of brain capital for economic growth, innovation, and well-being.
“The brain capital framework is based on the assumption that our brains are our greatest asset and provides an approach to define brain issues, quantify them, and track them,” said Dr. Eyre. “This perspective underscores the necessity to integrate brain capital considerations across society and public and private sectors.”
The Neurotech Collider Lab is well-positioned to play a key role in this global endeavor. The lab brings together researchers, entrepreneurs, and investors to work on neurotechnology solutions that have the potential to improve brain health and performance.
“We are excited to collaborate with the Brain Capital Alliance to advance this important work,” said Gannon. “By combining our expertise and resources, we can accelerate the development and commercialization of neurotechnology solutions that can make a positive impact on the world. We wish to catalyze Californian leadership in this area.”
The collaboration between the Neurotech Collider Lab and the Brain Capital Alliance is a testament to the growing recognition of the importance of brain health for individuals, societies, and economies. By working together, the two organizations can help to create a future where brain capital is central to human well-being.
Learn more about the Brain Capital Initiative: